A Phase 3 Study of the Use of PH80 for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder.

Trial Profile

A Phase 3 Study of the Use of PH80 for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder.

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs PH 80 (Primary)
  • Indications Premenstrual dysphoric disorder
  • Focus Therapeutic Use
  • Sponsors Pherin Pharmaceuticals
  • Most Recent Events

    • 02 Dec 2015 Planned End Date changed from 1 Oct 2013 to 1 Jul 2017, as reported by ClinicalTrials.gov.
    • 02 Dec 2015 Planned initiation date changed from 1 May 2011 to 1 Mar 2016, as reported by ClinicalTrials.gov.
    • 15 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top